This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., University of Regensburg. Active years: 2023.
Company Filing History:
1 out of 4,917 
1 out of 14 
Years Active: 2023
Title: The Innovative Contributions of Melanie Werner-Klein
Introduction
Melanie Werner-Klein is a notable inventor based in Wuppertal, Germany. She has made significant strides in the field of cancer research, particularly in the diagnosis and treatment of melanoma. Her work has the potential to impact the lives of many patients facing cancer diagnoses.
Latest Patents
Melanie holds a patent titled "Means and methods for staging, typing and treating a cancerous disease." This invention relates to methods for diagnosing, staging, and treating cancer, specifically melanoma. The patent provides innovative methods for determining the stage and type of a cancerous disease by detecting somatic alterations in the DNA of disseminated cancer cells (DCCs). These DCCs are obtained after homing to distant organs, such as lymph nodes. The methods outlined in her patent allow for a better understanding of the somatic evolution of DCCs, which is indicative of the cancer's stage and type.
Career Highlights
Throughout her career, Melanie has worked with esteemed institutions, including the University of Regensburg and Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Her contributions to cancer research have been recognized and valued in the scientific community.
Collaborations
Melanie has collaborated with talented individuals such as Isabelle Hodak and Sebastian Scheitler. These partnerships have further enriched her research and innovation in the field of cancer treatment.
Conclusion
Melanie Werner-Klein's work exemplifies the importance of innovation in medical research, particularly in the fight against cancer. Her patent and collaborations highlight her commitment to improving cancer diagnosis and treatment methods.